DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Beckley Foundation
Beckley Foundation
Annual Report 2018 -2019
CANNABIS Policy: Moving Beyond Stalemate
Psilocybin with Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up
An Update from the Beckley Foundation AMANDA FEILDING
NPS Amanda Feilding & Nicola Singleton TBC
The Rise and Decline of Cannabis Prohibition the History of Cannabis in the UN Drug Control System and Options for Reform
PRESS RELEASE Clinical Study Into LSD Microdosing Shows Strong Pain Management Potential 26Th August 2020, Oxford, UK / Maastricht, NL
Global Cannabis Research Leaders Beckley Foundation & Canopy Growth Partner to Form Beckley Canopy Therapeutics
0R, the Eclectic Workplace Acid Test
Idpc Drug Policy Guide 3Rd Edition
War on Drugs: Report of the Global Commission on Drug Policy
Amanda Feilding and the Beckley Foundation
BF Achievements Brochure
Beckley Foundation Lsd Research Programme
Scientific Programme 2019
Rethinking US Drug Policy
LSD Alters Eyes‐Closed Functional Connectivity
ANNUAL REPORT 2016-17 Psychedelic Research, Changing Minds
Top View
The Beckley Foundation: Working at the Frontiers of Research
RECALIBRATING the REGIME the Need for a Human Rights-Based Approach to International Drug Policy
MDMA Moore, K, Wells, H and Feilding, A
The Paradoxical Psychological Effects of Lysergic Acid Diethylamide (LSD)
2019‒2020 Annual Report
Module: Psilocybin History &
Amanda Feilding and the Beckley Foundation
Economic and Social Council Distr.: General 7 March 2017
Neural Correlates of the LSD Experience Revealed by Multimodal Neuroimaging
The Drug Policy Reform Agenda in the Americas (Version 2)
Roadmaps to Regulation: MDMA
Beckley Foundation Lsd Research Programme
Psilocybin with Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up
Powerpoint Template for a Scientific Poster
D-Lysergic Acid Diethylamide Has Major Potential As a Cognitive Enhancer
Licensing and Regulation of the Cannabis Market in England and Wales: Towards a Cost-Benefit Analysis
Global Cannabis Commission
The Beckley Foundation
Illicit Drugs Markets and Dimensions of Violence in Guatemala
Imperial College London's
LSD Fact Sheet
Amanda Feilding
Crop Eradication
Reclassification of Cannabis in the United Kingdom
Öäçä~Ä=Aord=Mlif`V== Pbjfk^O=OMMR= ===
Magic Mushrooms (Psilocybin) a Breakthrough Treatment for Depression
Paths for Reform
Roadmaps to Reforming the Un Drug Conventions
Report Roadmaps for Reforming the UN Drug Conventions
86632 Summary Cannabis Report Re-Print V6.Pub
CURRICULUM VITAE Alan Kooi Davis, Ph.D. Date: January 2020